Stifel Reiterates Buy Rating on Viridian Therapeutic (VRDN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: VRDN) | Delayed: 24.67 -0.13 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.80 | 52 Week High | $ | |||
| Open | $24.77 | 52 Week Low | $ | |||
| Day High | $25.00 | P/E | N/A | |||
| Day Low | $24.14 | EPS | $ | |||
| Volume | 1,710,585 | |||||
